The invention relates to a system comprising a device for neural stimulation of the cochlea, a device for acoustic stimulation of the same ear or the other ear and a fitting device for individually adjusting the neural stimulation device to the patient.
Typically, cochlear implants comprise an electrode array for electrical stimulation of the cochlear at various stimulation sites determined by the position of the respective electrode. Systems for bimodal stimulation of the hearing comprise a cochlear implant at the ipsilateral ear and a device for acoustic stimulation of the ipsilateral ear or the contraletral ear. Systems with electric and acoustic stimulation of the same ear are also known as hybrid devices or EAS devices. In systems with contralateral acoustic stimulation the acoustic stimulation device typically is an (electro-acoustic) hearing aid.
For optimal fitting of such bimodal systems knowledge about the location of the electrodes of the electrode array with regard to the cochlea after surgery is an important prerequisite.
In principle, the electrode location could be determined via CT (computer tomography) scans. However, such a method would be expensive and would require an additional appointment for the patient in another clinical department, and also there would be an additional radiation dose which is difficult to justify except for a diagnostic test directly impacting the patient's health.
A more practical approach is to use behavioral pitch matching for determining the pitch and the electrode location. An example of such procedure is discussed in the article “Pitch comparison to an electrical stimulation of a cochlear implant and acoustic stimuli presented to a normal-hearing contralateral ear” by R. Carlyon et al., in JARO 11, 2010, pages 625 to 640, wherein either pure tones or filtered harmonic complexes are presented to the normal hearing ear as acoustic stimuli and electric stimuli are presented as biphasic pulse trains presented in monopolar mode to one electrode, with the acoustic stimuli and the electric stimuli being presented simultaneously or subsequently to the patient. Unfortunately, such pitch matching procedure is very tedious and unreliable.
According to the article “Contralateral masking in cochlear implant users with residual hearing in the non-implanted ear” by C. James et al., Audiology & Neuro-Otology 6, 2011, pages 87 to 97, threshold elevations for electrical stimulation probes were observed when acoustic contralateral maskers were presented; the acoustic masking signals were tones or narrow band noise signals.
US 2005/0261748 A1 relates to a fitting method for a hybrid device used by a patient having residual acoustic hearing capability at the ipsilateral ear, wherein the portion of the cochlea having residual acoustic hearing capability is determined by measuring the neural response to acoustic and/or electrical stimulation. Acoustic background noise, in particular narrow band background stimulus of a frequency substantially corresponding to the position of the tip electrode, is applied together with an electrical stimulus in order to determine from ECAP measurements which portion of the cochlear has residual acoustic hearing capability, with the ECAP measurements being used to determine a frequency-electrode position map.
US 2011/0238176 A1 likewise relates to a fitting method for a hybrid device, wherein a tonotopic response for the residual hearing of the ipsilateral cochlear is measured to obtain a place-frequency map, the CI implant is inserted according to the place-frequency map, and the position of the CI then is confirmed according to the measured place-frequency map via the measurement of the evoked neural response, such as the auditory brainstem response (ABR), to electrical stimulation of the CI and simultaneous acoustic stimulation. The acoustic stimulus is a customized chirp signal.
It is an object of the invention to provide for a bimodal stimulation system comprising a fitting device allowing for fast, easy, reliable and clinically appropriate determination of electrode positions after surgery for patients with residual hearing at the ipsilateral and/or contralateral ear. It is also an object to provide for a corresponding bimodal fitting method.
According to the invention, these objects are achieved by systems as defined in claims 1 and 3 respectively and methods as defined in claims 28 and 29, respectively.
The invention is beneficial in that by using a notch-type acoustic broadband masking signal for obtaining a perceptual behavioral response of the patient to synchronized neural stimulation of the ipsilateral cochlear with the probe neural stimulation signal and the acoustic stimulation of the contralateral or ipsilateral ear with the notch-type acoustic broadband masking signal, the perceived frequency of the neural stimulation sites can be determined in a fast, simple, reliable and clinically appropriate manner. In particular, such frequency determination by applying an acoustic masking signal having a notch frequency region is easier and more reliable than a pitch matching procedure in which the perception of the neural stimulus is compared to acoustic stimulation by a pure tone or a narrowband signal.
Preferred embodiments are defined in the dependent claims.
Hereinafter, the invention will be illustrated by reference to the attached drawings, wherein:
The programming unit 13 serves to control the sound processing subsystem 11 of the CI device 10 such that probe neural stimulation signals are applied to the ipsilateral ear of the patient 17 via the stimulation subsystem 12 and to control the hearing aid 21 such that acoustic broadband masking signals are presented via the loudspeaker 23 to the contralateral ear of the patient 17 in a synchronized manner with regard to the probe neural stimulation. The perceptual behaviorial response of the patient 17 to the such synchronized stimulation is recorded by the programming unit 13 via a user interface, which may be part of the programming unit (such as the computer keyboard) or may be provided separately (as schematically indicated at 25 in
It is to be understood that the programming unit 13 is used with the CI device 10 and the hearing aid 21 only for adjustment/fitting, but not during normal operation of the CI device 10 and the hearing aid 21.
In case that the fitting/programming unit 13 is adapted to generate audio signals/stimulation signals on its own, the programming interface 15 may be replace by an audio interface for supplying the audio signals generated by the fitting/programming unit 13 to the CI device.
In
Stimulation sub-system 12 serves to generate and apply electrical stimulation (also referred to herein as “stimulation current” and/or “stimulation pulses”) to stimulation sites at the auditory nerve within the cochlear of a patient 17 in accordance with the stimulation parameters received from the sound processing sub-system 11. Electrical stimulation is provided to the patient 17 via a CI stimulation assembly 18 comprising a plurality of stimulation channels, wherein various known stimulation strategies, such as current steering stimulation or N-of-M stimulation, may be utilized.
As used herein, a “current steering stimulation strategy” is one in which weighted stimulation current is applied concurrently to two or more electrodes by an implantable cochlear stimulator in order to stimulate a stimulation site located in between areas associated with the two or more electrodes and thereby create a perception of a frequency in between the frequencies associated with the two or more electrodes, compensate for one or more disabled electrodes, and/or generate a target pitch that is outside a range of pitches associated with an array of electrodes.
As used herein, an “N-of-M stimulation strategy” is one in which stimulation current is only applied to N of M total stimulation channels during a particular stimulation frame, where N is less than M. An N-of-M stimulation strategy may be used to prevent irrelevant information contained within an audio signal from being presented to a CI user, achieve higher stimulation rates, minimize electrode interaction, and/or for any other reason as may serve a particular application.
The stimulation parameters may control various parameters of the electrical stimulation applied to a stimulation site including, but not limited to, frequency, pulse width, amplitude, waveform (e.g., square or sinusoidal), electrode polarity (i.e., anode-cathode assignment), location (i.e., which electrode pair or electrode group receives the stimulation current), burst pattern (e.g., burst on time and burst off time), duty cycle or burst repeat interval, spectral tilt, ramp on time, and ramp off time of the stimulation current that is applied to the stimulation site.
Returning to
In the example shown in
In the example shown in
In the example shown in
In
After appropriate automatic gain control, the digital signal is subjected to a filterbank 38 comprising a plurality of filters F1 . . . Fm (for example, band-pass filters) which are configured to divide the digital signal into m analysis channels 40, each containing a signal representative of a distinct frequency portion of the audio signal sensed by the microphone 20. For example, such frequency filtering may be implemented by applying a Discrete Fourier Transform to the audio signal and then distribute the resulting frequency bins across the analysis channels 40.
The signals within each analysis channel 40 are input into an envelope detector 42 in order to determine the amount of energy contained within each of the signals within the analysis channels 40 and to estimate the noise within each channel. After envelope detection the signals within the analysis channels 40 may be input into a noise reduction module 44, wherein the signals are treated in a manner so as to reduce noise in the signal in order to enhance, for example, the intelligibility of speech by the patient. Examples of the noise reduction module 44 are described in WO 2011/032021 A1.
The optionally noise reduced signals are supplied to a mapping module 46 which serves to map the signals in the analysis channels 40 to the stimulation channels S1 . . . Sn. For example, signal levels of the noise reduced signals may be mapped to amplitude values used to define the electrical stimulation pulses that are applied to the patient 17 by the ICS 14 via M stimulation channels 52. For example, each of the m stimulation channels 52 may be associated to one of the stimulation contacts 19 or to a group of the stimulation contacts 19.
The sound processor 24 further comprises a stimulation strategy module 48 which serves to generate one or more stimulation parameters based on the noise reduced signals and in accordance with a certain stimulation strategy (which may be selected from a plurality of stimulation strategies). For example, stimulation strategy module 48 may generate stimulation parameters which direct the ICS 14 to generate and concurrently apply weighted stimulation current via a plurality 52 of the stimulation channels S1 . . . Sn in order to effectuate a current steering stimulation strategy. Additionally or alternatively the stimulation strategy module 48 may be configured to generate stimulation parameters which direct the ICS 14 to apply electrical stimulation via only a subset N of the stimulation channels 52 in order to effectuate an N-of-M stimulation strategy.
The sound processor 24 also comprises a multiplexer 50 which serves to serialize the stimulation parameters generated by the stimulation strategy module 48 so that they can be transmitted to the ICS 14 via the communication link 30, i.e. via the coil 28.
The sound processor 24 may operate in accordance with at least one control parameter which is set by a control unit 54. Such control parameters, which may be stored in a memory 56, may be the most comfortable listening current levels (MCL), also referred to as “M levels”, threshold current levels (also referred to as “T levels”), dynamic range parameters, channel acoustic gain parameters, front and back end dynamic range parameters, current steering parameters, amplitude values, pulse rate values, pulse width values, polarity values, the respective frequency range assigned to each electrode and/or filter characteristics. Examples of such auditory prosthesis devices, as described so far, can be found, for example, in WO 2011/032021 A1.
The programming unit 13 acts on the control unit 54 via the interface 15 for causing the ICS 14 and the electrode array 19 to apply a certain probe stimulus to the cochlear 200 as will be discussed in detail below.
The hearing aid 21 comprises a microphone arrangement 29 for capturing audio signals from ambient sound, an audio signal processing unit 27 for processing the captured audio signals and the loudspeaker 23 to which the processed audio signals are supplied to. The programming unit 13 acts, via the interface 15, on the audio signal processing unit 27 in order to cause the loudspeaker 23 to emit broadband masking signals supplied to the contralateral ear in a synchronized manner with regard to the probe stimulus applied by the CI device 10.
Hereinafter, an example of the fitting procedure will be described by reference to
As a first step, the electrode to be investigated is to be selected (usually it will be sufficient to determine the frequency/position of one electrode, since then the frequencies of the other electrodes can be estimated by applying an appropriate model, such as the Greenwood formulae or another procedure to calculate pitch from location or angle in the cochlea. The criteria for selecting the probe electrode may include discriminability, tonal perception, electrical impedance and/or ECAP patterns. Corresponding tests/experiments/measurements may be carried out for determining such parameters. For example, measurements using current steering may be conducted for estimating the sensitivity of each electrode with regard to pitch matching (and hence estimating the “independence” of different parts of the cochlea).
Further, the most appropriate neural stimulation method has to be selected, such as a “Simultaneous Analog Strategy” (SAS) or “Continuous Interleaved Sampling” (CIS). Also the most appropriate electrode coupling mode has to be selected, such as a multipolar or tripolar stimulation mode in order to provide for a “cleaner” probe signal for the masking experiment. The selected electrode may be activated in a pulsating manner (non-periodical/periodical) e.g. 500 ms on and 500 ms off.
The general goal of electrode and stimulation selection is to provide for a probe neural stimulus which is as “tonal” as possible.
As a next step, masking experiments are carried out, wherein an acoustic broadband masking signal and the probe neural stimulation signal are presented to the patient in a synchronized manner, the perceptual response of the patient is recorded and the acoustic broadband masking signal and/or the probe stimulation signal are varied in response to the recorded perceptual response by the patient, thereby implementing an iterative procedure. During such a procedure it is usually sufficient that the patient provides for feedback as to whether the probe stimulus is audible (i.e. is not masked by the acoustic signal) or is inaudible (i.e. is masked by the acoustic signal).
As a first step of the masking experiments, the acoustic signal is provided as a start broadband signal having an essentially constant excitation level over frequency (the frequency with regard to the neural stimulation corresponds to the distance from the apex of the cochlea). The experiment may start with a relatively low level of the acoustic signal which does not result in masking of the excitation of the probe stimulus. The level of the acoustic start broadband masking signal then is increased step by step until the probe stimulus becomes inaudible (see
As an next step of the masking experiment, a notch acoustic broadband masking signal is applied which includes a notch frequency region having a noise level below the masking level of the probe stimulus, with the noise level outside the notch frequency region being above the masking level of probe stimulus.
An example of such notch masking signal is shown in
According to one example, the base level may equal the threshold masking level of the start broadband masking signal.
In the example of
there is no excitation of the ipsilateral ear within the notch frequency region. However, the noise level within notch frequency range also may be above zero as long as it is relatively low, so that no masking occurs within the notch frequency region.
The audibility of the probe stimulus depends on the position of the notch frequency region, i.e. on the center frequency thereof. In the example of
The notch masking signals of the type shown in
Preferably, base noise level and the noise level in the notch frequency region are constant during determining that set of audible notch masking signals.
Preferably, the level within the notch frequency region is at least 10 dB less than the frequency-averaged base level (i.e. the level outside the notch frequency region) when determining the set of audible notch masking signals. Preferably, the slope at the edges of the notch frequency region is at least 30 dB/octave.
As a next step, for each member of the set of audible notch masking signals the level within the notch frequency region is readily or stepwise increased until a notch threshold level Lnt is reached at which the probe stimulus becomes inaudible. Thus, for each member of the set of audible notch masking signals a respective notch threshold level Lnt is obtained. The notch region center frequency of that member of the set of audible notch masking signals having the highest notch threshold level is assumed to correspond to the frequency fe of the probe electrode in order to obtain the value of the frequency fe of the probe electrode as the result of the masking experiments.
In some cases it may be appropriate to apply empirical corrections to the measurement results, so that the electrode frequency is derived from the notch region center frequency of the notch masking signal having the highest notch threshold level.
In the above described masking experiments, the masking threshold levels may be determined as a standard audiometry, with the patient, for example, pressing or releasing a button when the probe signal is no longer audible.
Since the audibility of the probe signal with regard to the masking signal only depends on the relative excitation levels, the above described procedure may be modified by keeping the level of the masking signal constant while varying the level of the probe stimulus. In this case, the level of the masking signal within the notch frequency region would be kept constant for each member of the set of audible notch masking signals, while the level of the probe stimulus is decreased stepwise. In the next step, that member of the set of audible notch masking signals would be taken as the “winner” for which the probe stimulus becomes inaudible at the lowest probe stimulus level. Similarly, also the step illustrated in
In general, in the parts of the procedure involving level changes the relevant measure is the ratio of the probe stimulus level and the acoustic masking level.
Finally, the frequencies of the other electrodes may be estimated from the determined frequency of the probe electrode by applying a suitable model such as the Greenwood formulae or UCSF mapping.
According to a variant, the acoustic masking signals may be provided to the ipsilateral ear rather than to the contralateral ear. hi this case, the device worn at the ipsilateral ear may be a hybrid device providing both for electrical and acoustic stimulation of the ipsilateral ear, as indicated in dashed lines in
According to a further variant, the neural stimulation may include optical stimulation of the cochlea in addition to or instead of the above described electrical stimulation, i.e. in this case an optical stimulus may be applied at the stimulation site in addition to or instead of an electrical stimulus.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2013/064251 | 7/5/2013 | WO | 00 |